Jason Haas sold $1.7M of Ligand Pharmaceuticals Incorporated (LGND)

Executed Jun 12, disclosed Jun 15, 3 days later.

Value, as filed

$1.7M

6,461 sh across 2 lots

Executed

Jun 12

the trade date, as filed

Disclosed

Jun 15

3 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Jason Haas Director profile →

Jason Haas (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Ligand Pharmaceuticals Incorporated (LGND). The largest single filing was $2.1M of LGND (7,138 sh × $292.81, as filed), executed Aug 12.

The name

LGND

Ligand Pharmaceuticals Incorporated LGND · Healthcare · 36 filings in 24 months ticker →

Healthcare · Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Jason Haas in LGND

LGNDSALE Ligand Pharmaceuticals Incorporated $2.1M
7,138 sh × $292.81
Exec Aug 12
Filed Aug 14 · 5:04 PM ET